angiotensin ii has been researched along with norethindrone acetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roberts, JM | 1 |
| Ballagh, SA; Eggena, P; Jackanicz, TM; Lacarra, M; Mishell, DR; Shoupe, D | 1 |
1 review(s) available for angiotensin ii and norethindrone acetate
| Article | Year |
|---|---|
Oestrogens and hypertension.
Topics: Adolescent; Adult; Age Factors; Angiotensin II; Cardiac Output; Cardiovascular Diseases; Contraceptives, Oral; Estrogens; Female; Humans; Hypertension; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Pituitary-Adrenal System; Progestins; Prospective Studies; Prostaglandins; Renin; Renin-Angiotensin System; Sympathetic Nervous System | 1981 |
1 trial(s) available for angiotensin ii and norethindrone acetate
| Article | Year |
|---|---|
A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol.
Topics: Administration, Intravaginal; Adult; Angiotensin II; Cholesterol, HDL; Contraceptive Devices, Female; Delayed-Action Preparations; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Luteal Phase; Menstrual Cycle; Nausea; Norethindrone; Norethindrone Acetate; Sex Hormone-Binding Globulin; Triglycerides | 1994 |